Moreover, studies showed that ctDNA detection might identify patients with a higher risk of BR, indicating that ctDNA detection could also be used as a biomarker to identify localized PCa patients that might present detectable PSA post-surgery or BR [26,28,29]. Here, KLK3 is linked to posterior cortical atrophy.